Literature DB >> 2892058

Treatable aspects of infection due to human immunodeficiency virus.

L S Young1.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 2892058     DOI: 10.1016/s0140-6736(87)92632-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment.

Authors:  R A Hague; P L Yap; J Y Mok; O B Eden; N A Coutts; J G Watson; F D Hargreaves; J M Whitelaw
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

Review 2.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 3.  Aerosol therapy in AIDS.

Authors:  S P Newman; A K Simonds
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals.

Authors:  B Y Lee; D Chatterjee; C M Bozic; P J Brennan; D L Cohn; J D Bales; S M Harrison; L A Andron; I M Orme
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

5.  Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.

Authors:  S De Wit; D Urbain; F Rahir; D Weerts; N Clumeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

6.  Esophageal candidiasis in AIDS. Successful therapy with clotrimazole vaginal tablets taken by mouth.

Authors:  E Lalor; L Rabeneck
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.